OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 146.62% | 144.36% | 125.52% | 100.14% | 44.91% |
| Total Depreciation and Amortization | -1.04% | 0.77% | 3.74% | 5.86% | 22.83% |
| Total Amortization of Deferred Charges | 3.19% | 49.47% | 13.29% | 8.49% | 51.13% |
| Total Other Non-Cash Items | -48.49% | -56.73% | -61.75% | -71.11% | -23.46% |
| Change in Net Operating Assets | 107.04% | -701.56% | 21.61% | 83.97% | 86.03% |
| Cash from Operations | 77.01% | 116.79% | 282.80% | 854.63% | 652.47% |
| Capital Expenditure | -6.94% | 51.40% | 48.21% | 36.00% | 37.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 180.97% | 166.79% | 137.28% | -100.36% | -100.50% |
| Cash from Investing | 141.18% | 134.38% | 115.11% | 99.02% | 98.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -332.54% | -154.78% | -100.00% | -149.22% | -195.20% |
| Issuance of Common Stock | -- | -- | -- | 2,153.33% | -- |
| Repurchase of Common Stock | -150.22% | -25.87% | -26.23% | 30.15% | 40.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.08% | -124.76% | -79.15% | -123.97% | -124.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 361.93% | 157.59% | 2,215.47% | -45.30% | -68.44% |